Aytu Biopharma AYTU
NASDAQ AYTU
$1.79 -0.04 (-2.19%)
At close: Nov 9, 2026 · 4:00 PM EST

Aytu Biopharma (AYTU) Current Deferred Revenue (2014 - 2020)

Updated

Aytu Biopharma (AYTU) posted Current Deferred Revenue of $475,680 for fiscal Q2 2021 (quarter ended Dec 31, 2020), up 104.5% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Current Deferred Revenue (2014 - 2020) Analysis & Trends

At the end of FY2020 (ended Jun 30, 2020), Aytu Biopharma's Current Deferred Revenue came in at $339,336.

  • Annual Current Deferred Revenue shows a five-year compound annual growth rate of 31.7% (FY2015 to FY2020).
  • The fiscal Q2 2021 figure stands as the highest quarterly Current Deferred Revenue in data going back to fiscal Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Aytu Biopharma 22.17 Mn -93.50 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 475,680.00
Sep 30, 2020 232,576.00
Jun 30, 2020 339,336.00
Dec 31, 2018 13,990.00
Mar 31, 2016 85,714.00
Dec 31, 2015 85,714.00
Sep 30, 2015 85,714.00
Jun 30, 2015 85,714.00
Mar 31, 2015 85,714.00
Jun 30, 2014 85,714.00
API Access

Aytu Biopharma Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AYTU&period=max&api_key=YOUR_API_KEY